DSpace@İnönü

Yazar "Wahlin, S" için listeleme

Yazar "Wahlin, S" için listeleme

Sırala: Sıra: Sonuçlar:

  • Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated 
    Efe, C; Tascilar, K; Henriksson, I; Lytvyak, E; Alalkim, F; Trivedi, H; Eren, F; Eliasson, J; Beretta-Piccoli, BT; Fischer, J; Caliskan, AR; Chayanupatkul, M; Coppo, C; Ytting, H; Purnak, T; Muratori, L; Werner, M; Muratori, P; Rorsman, F; Onnerhag, K; Gunsar, F; Nilsson, E; Heurgue-Berlot, A; Guzelbulut, F; Demir, N; Gonen, C; Semela, D; Aladag, M; Kiyici, M; Schiano, T; Montano-Loza, A; Berg, T; Ozaslan, E; Yoshida, E; Bonder, A; Marschall, HU; Wahlin, S (2019)
    INTRODUCTION: Risk stratification based on biochemical variables is a useful tool for monitoring ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC). Several UDCA response criteria and scoring ...
  • Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated 
    Efe, C; Tascilar, K; Henriksson, I; Lytvyak, E; Alalkim, F; Trivedi, H; Eren, F; Eliasson, J; Beretta-Piccoli, BT; Fischer, J; Caliskan, AR; Chayanupatkul, M; Coppo, C; Ytting, H; Purnak, T; Muratori, L; Werner, M; Muratori, P; Rorsman, F; Onnerhag, K; Gunsar, F; Nilsson, E; Heurgue-Berlot, A; Guzelbulut, F; Demir, N; Gonen, C; Semela, D; Aladag, M; Kiyici, M; Schiano, T; Montano-Loza, A; Berg, T; Ozaslan, E; Yoshida, E; Bonder, A; Marschall, HU; Wahlin, S (2019)
    INTRODUCTION: Risk stratification based on biochemical variables is a useful tool for monitoring ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC). Several UDCA response criteria and scoring ...
  • Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated 
    Efe, C; Tascilar, K; Henriksson, I; Lytvyak, E; Alalkim, F; Trivedi, H; Eren, F; Eliasson, J; Beretta-Piccoli, BT; Fischer, J; Caliskan, AR; Chayanupatkul, M; Coppo, C; Ytting, H; Purnak, T; Muratori, L; Werner, M; Muratori, P; Rorsman, F; Onnerhag, K; Gunsar, F; Nilsson, E; Heurgue-Berlot, A; Guzelbulut, F; Demir, N; Gonen, C; Semela, D; Aladag, M; Kiyici, M; Schiano, T; Montano-Loza, A; Berg, T; Ozaslan, E; Yoshida, E; Bonder, A; Marschall, HU; Wahlin, S (2019)
    INTRODUCTION: Risk stratification based on biochemical variables is a useful tool for monitoring ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC). Several UDCA response criteria and scoring ...
  • Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An 
    Efe, C; Dhanasekaran, R; Lammert, C; Ebik, B; Higuera-de la Tijera, F; Aloman, C; Caliskan, AR; Peralta, M; Gerussi, A; Massoumi, H; Catana, AM; Torgutalp, M; Purnak, T; Rigamonti, C; Aldana, AJG; Khakoo, N; Kacmaz, H; Nazal, L; Frager, S; Demir, N; Irak, K; Ellik, ZM; Balaban, Y; Atay, K; Eren, F; Cristoferi, L; Batibay, E; Urzua, A; Snijders, R; Kiyici, M; Akyildiz, M; Ekin, N; Carr, RM; Harputluoglu, M; Hatemi, I; Mendizabal, M; Silva, M; Idilman, R; Silveira, M; Drenth, JPH; Assis, DN; Bjornsson, E; Boyer, JL; Invernizzi, P; Levy, C; Schiano, TD; Ridruejo, E; Wahlin, S (2021)
    Background and Aims Data regarding outcome of COVID-19 in patients with autoimmune hepatitis (AIH) are lacking.
  • Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An 
    Efe, C; Dhanasekaran, R; Lammert, C; Ebik, B; Higuera-de la Tijera, F; Aloman, C; Caliskan, AR; Peralta, M; Gerussi, A; Massoumi, H; Catana, AM; Torgutalp, M; Purnak, T; Rigamonti, C; Aldana, AJG; Khakoo, N; Kacmaz, H; Nazal, L; Frager, S; Demir, N; Irak, K; Ellik, ZM; Balaban, Y; Atay, K; Eren, F; Cristoferi, L; Batibay, E; Urzua, A; Snijders, R; Kiyici, M; Akyildiz, M; Ekin, N; Carr, RM; Harputluoglu, M; Hatemi, I; Mendizabal, M; Silva, M; Idilman, R; Silveira, M; Drenth, JPH; Assis, DN; Bjornsson, E; Boyer, JL; Invernizzi, P; Levy, C; Schiano, TD; Ridruejo, E; Wahlin, S (2021)
    Background and Aims Data regarding outcome of COVID-19 in patients with autoimmune hepatitis (AIH) are lacking.
  • Effects of immunosuppressive drugs on COVID-19 severity in patients with 
    Efe, C; Lammert, C; Tascilar, K; Dhanasekaran, R; Ebik, B; Higuera-de la Tijera, F; Caliskan, AR; Peralta, M; Gerussi, A; Massoumi, H; Catana, AM; Purnak, T; Rigamonti, C; Aldana, AJG; Khakoo, N; Nazal, L; Frager, S; Demir, N; Irak, K; Melekoglu-Ellik, Z; Kacmaz, H; Balaban, Y; Atay, K; Eren, F; Alvares-da-Silva, MR; Cristoferi, L; Urzua, A; Eskazan, T; Magro, B; Snijders, R; Barutcu, S; Lytvyak, E; Zazueta, GM; Demirezer-Bolat, A; Aydin, M; Heurgue-Berlot, A; De Martin, E; Ekin, N; Yildirim, S; Yavuz, A; Biyik, M; Narro, GC; Kiyici, M; Akyildiz, M; Kahramanoglu-Aksoy, E; Vincent, M; Carr, RM; Gunsar, F; Reyes, EC; Harputluoglu, M; Aloman, C; Gatselis, NK; Ustundag, Y; Brahm, J; Vargas, NCE; Guzelbulut, F; Garcia, SR; Aguirre, J; Anders, M; Ratusnu, N; Hatemi, I; Mendizabal, M; Floreani, A; Fagiuoli, S; Silva, M; Idilman, R; Satapathy, SK; Silveira, M; Drenth, JPH; Dalekos, GN; Assis, DN; Bjornsson, E; Boyer, JL; Yoshida, EM; Invernizzi, P; Levy, C; Montano-Loza, AJ; Schiano, TD; Ridruejo, E; Wahlin, S (2022)
    Background We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods Data of AIH patients with ...
  • Effects of immunosuppressive drugs on COVID-19 severity in patients with 
    Efe, C; Lammert, C; Tascilar, K; Dhanasekaran, R; Ebik, B; Higuera-de la Tijera, F; Caliskan, AR; Peralta, M; Gerussi, A; Massoumi, H; Catana, AM; Purnak, T; Rigamonti, C; Aldana, AJG; Khakoo, N; Nazal, L; Frager, S; Demir, N; Irak, K; Melekoglu-Ellik, Z; Kacmaz, H; Balaban, Y; Atay, K; Eren, F; Alvares-da-Silva, MR; Cristoferi, L; Urzua, A; Eskazan, T; Magro, B; Snijders, R; Barutcu, S; Lytvyak, E; Zazueta, GM; Demirezer-Bolat, A; Aydin, M; Heurgue-Berlot, A; De Martin, E; Ekin, N; Yildirim, S; Yavuz, A; Biyik, M; Narro, GC; Kiyici, M; Akyildiz, M; Kahramanoglu-Aksoy, E; Vincent, M; Carr, RM; Gunsar, F; Reyes, EC; Harputluoglu, M; Aloman, C; Gatselis, NK; Ustundag, Y; Brahm, J; Vargas, NCE; Guzelbulut, F; Garcia, SR; Aguirre, J; Anders, M; Ratusnu, N; Hatemi, I; Mendizabal, M; Floreani, A; Fagiuoli, S; Silva, M; Idilman, R; Satapathy, SK; Silveira, M; Drenth, JPH; Dalekos, GN; Assis, DN; Bjornsson, E; Boyer, JL; Yoshida, EM; Invernizzi, P; Levy, C; Montano-Loza, AJ; Schiano, TD; Ridruejo, E; Wahlin, S (2022)
    Background We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods Data of AIH patients with ...
  • Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated 
    Efe, C; Kulkarni, AV; Beretta-Piccoli, BT; Magro, B; Stattermayer, AF; Cengiz, M; Clayton-Chubb, D; Lammert, C; Bernsmeier, C; Gul, O; Higuera-de la Tijera, FH; Anders, M; Lytvyak, E; Akin, M; Purnak, T; Liberal, R; Peralta, M; Ebik, B; Duman, S; Demir, N; Balaban, Y; Urzua, A; Contreras, F; Venturelli, MG; Bilgic, Y; Medina, A; Girala, M; Gunsar, F; Londono, MC; Androutsakos, T; Kisch, A; Yurci, A; Guzelbult, F; Cagin, YF; Avci, E; Guzelbulut, M; Dindar-Demiray, EK; Harputluoglu, M; Kumar, R; Satapathy, SK; Mendizabal, M; Silva, M; Fagiuoli, S; Roberts, SK; Soylu, NK; Idilman, R; Yoshida, EM; Montano-Loza, AJ; Dalekos, GN; Ridruejo, E; Schiano, TD; Wahlin, S (2022)
    Background and Aims A few case reports of autoimmune hepatitis-like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment ...
  • Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated 
    Efe, C; Kulkarni, AV; Beretta-Piccoli, BT; Magro, B; Stattermayer, AF; Cengiz, M; Clayton-Chubb, D; Lammert, C; Bernsmeier, C; Gul, O; Higuera-de la Tijera, FH; Anders, M; Lytvyak, E; Akin, M; Purnak, T; Liberal, R; Peralta, M; Ebik, B; Duman, S; Demir, N; Balaban, Y; Urzua, A; Contreras, F; Venturelli, MG; Bilgic, Y; Medina, A; Girala, M; Gunsar, F; Londono, MC; Androutsakos, T; Kisch, A; Yurci, A; Guzelbult, F; Cagin, YF; Avci, E; Guzelbulut, M; Dindar-Demiray, EK; Harputluoglu, M; Kumar, R; Satapathy, SK; Mendizabal, M; Silva, M; Fagiuoli, S; Roberts, SK; Soylu, NK; Idilman, R; Yoshida, EM; Montano-Loza, AJ; Dalekos, GN; Ridruejo, E; Schiano, TD; Wahlin, S
    Background and Aims A few case reports of autoimmune hepatitis-like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment ...